AVXL: Anavex Life Sciences Corp. Stocks News on October 22, 2025

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

AVXL

GlobeNewswire

12 days ago

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

AVXL

MT Newswires

20 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

AVXL

MT Newswires

20 days ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

AVXL

MT Newswires

20 days ago

Anavex Says Phase 1b Trial of Once-Daily Oral Tablet for Adults With Schizophrenia Met Safety, Tolerability Endpoints

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

AVXL

GlobeNewswire

20 days ago

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

AVXL

GlobeNewswire

20 days ago

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial

AVXL

GlobeNewswire

a month ago

Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial

AVXL

Zacks

3 months ago

Are You Looking for a Top Momentum Pick? Why Anavex Life Sciences (AVXL) is a Great Choice

High Growth Tech Stocks To Watch In The US June 2025

AVXL

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In The US June 2025

AVXL

Simply Wall St.

4 months ago

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn

AVXL

Simply Wall St.

5 months ago

Anavex Life Sciences Corp.'s (NASDAQ:AVXL) largest shareholders are individual investors with 60% ownership, institutions own 37%

AVXL

GuruFocus.com

5 months ago

Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlights: Promising Alzheimer's Data ...

Anavex Life Sciences to Participate at Upcoming Healthcare Conferences

AVXL

GlobeNewswire

5 months ago

Anavex Life Sciences to Participate at Upcoming Healthcare Conferences

AVXL

Associated Press Finance

5 months ago

Anavex Life Sciences: Fiscal Q2 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update

AVXL

GlobeNewswire

5 months ago

Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update

AVXL

Insider Monkey

5 months ago

Is Anavex Life Sciences Corp. (AVXL) the Low Risk High Reward Stock Set to Triple by 2030?

Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025

AVXL

GlobeNewswire

6 months ago

Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025

AVXL

MT Newswires

6 months ago

Anavex Life Sciences' Schizophrenia Clinical Study Completes Enrollment

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

AVXL

GlobeNewswire

6 months ago

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Anavex Life Sciences to Participate in The Citizens Life Sciences Conference

AVXL

GlobeNewswire

6 months ago

Anavex Life Sciences to Participate in The Citizens Life Sciences Conference

Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

AVXL

GlobeNewswire

6 months ago

Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

AVXL

GuruFocus.com

6 months ago

Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ...

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

AVXL

GlobeNewswire

6 months ago

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

High Growth Tech Stocks To Watch In The US Market

AVXL

Simply Wall St.

6 months ago

High Growth Tech Stocks To Watch In The US Market

AD/PD 2025: Long-term data shows Anavex’s Blarcamesine benefits in early Alzheimer’s

AVXL

Clinical Trials Arena

6 months ago

AD/PD 2025: Long-term data shows Anavex’s Blarcamesine benefits in early Alzheimer’s

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years

AVXL

Benzinga

6 months ago

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

AVXL

GlobeNewswire

7 months ago

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

AVXL

GlobeNewswire

7 months ago

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

Exploring 3 High Growth Tech Stocks In The US Market

AVXL

Simply Wall St.

8 months ago

Exploring 3 High Growth Tech Stocks In The US Market

AVXL

Simply Wall St.

8 months ago

Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

AVXL

GlobeNewswire

8 months ago

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

AVXL

Associated Press Finance

8 months ago

Anavex Life Sciences: Fiscal Q1 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update

AVXL

GlobeNewswire

8 months ago

Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update

Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025

AVXL

GlobeNewswire

9 months ago

Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025

AVXL

Insider Monkey

9 months ago

Jim Cramer on Anavex Life Sciences Corp. (AVXL): ‘It’s A Good Spec’

Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

AVXL

GlobeNewswire

9 months ago

Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why

AVXL

Zacks

9 months ago

Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why

Best Momentum Stocks to Buy for January 21st

AVXL

Zacks

9 months ago

Best Momentum Stocks to Buy for January 21st

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease

AVXL

GlobeNewswire

9 months ago

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease

New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

AVXL

GlobeNewswire

9 months ago

New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

AVXL

GlobeNewswire

10 months ago

Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

AVXL

Zacks

10 months ago

Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?

AVXL

Zacks

10 months ago

All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy

Anavex price target raised to $42 from $40 at H.C. Wainwright

AVXL

TipRanks

10 months ago

Anavex price target raised to $42 from $40 at H.C. Wainwright

Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability

AVXL

TipRanks

10 months ago

Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability

AVXL

Simply Wall St.

10 months ago

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn

AVXL

GuruFocus.com

10 months ago

Anavex Life Sciences Corp (AVXL) Q4 2024 Earnings Call Highlights: Strong Cash Position and ...

AVXL

Thomson Reuters StreetEvents

10 months ago

Q4 2024 Anavex Life Sciences Corp Earnings Call

AVXL

MT Newswires

10 months ago

Anavex Says it Gets EMA Filing Acceptance for Blarcamesine to Treat Alzheimer's Disease

AVXL

Associated Press Finance

10 months ago

Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

AVXL

GlobeNewswire

10 months ago

Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease

AVXL

GlobeNewswire

10 months ago

Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease

Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024

AVXL

GlobeNewswire

10 months ago

Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference

AVXL

GlobeNewswire

10 months ago

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference

Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024

AVXL

MT Newswires

a year ago

Anavex Submits Marketing Authorization Application to EU Regulator for Blarcamesine to Treat Alzheimer's; Shares Jump Pre-Bell

Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA

Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal

Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024

AVXL

GlobeNewswire

a year ago

Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

AVXL

GuruFocus.com

a year ago

Anavex Life Sciences Corp (AVXL) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

AVXL

Simply Wall St.

a year ago

Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?

Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024

AVXL

Associated Press Finance

a year ago

Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update

Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024

Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference

AVXL

MT Newswires

a year ago

Anavex Life Sciences Files $150 Million Shelf

Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39%

AVXL

Benzinga

a year ago

Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39%

Anavex seek EMA approval despite shaky pivotal Alzheimer’s trial data

AVXL

Clinical Trials Arena

a year ago

Anavex seek EMA approval despite shaky pivotal Alzheimer’s trial data

Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference

AVXL

GlobeNewswire

a year ago

Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference

Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion

AVXL

Zacks

a year ago

Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion

HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails

AVXL

Zacks

a year ago

HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails

AVXL

Simply Wall St.

a year ago

Institutions own 38% of Anavex Life Sciences Corp. (NASDAQ:AVXL) shares but individual investors control 59% of the company

Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

AVXL

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AVXL

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AVXL

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AVXL

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

AVXL

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

AVXL

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

AVXL

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

AVXL

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

AVXL

MT Newswires

a year ago

Sector Update: Health Care Stocks Slightly Higher Late Afternoon

AVXL

MT Newswires

a year ago

Anavex Life Sciences Expands Leadership Team; Shares Rise

Anavex Life Sciences Announces Expansion of Leadership Team

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences Announces Expansion of Leadership Team

AVXL

Simply Wall St.

a year ago

Anavex Life Sciences (NASDAQ:AVXL) Is In A Good Position To Deliver On Growth Plans

AVXL

Zacks

a year ago

Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

AVXL

Insider Monkey

a year ago

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call Transcript

AVXL

Associated Press Finance

a year ago

Anavex Life Sciences: Fiscal Q2 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

AVXL

GlobeNewswire

a year ago

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

AVXL

GlobeNewswire

2 years ago

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

AVXL

GlobeNewswire

2 years ago

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia

AVXL

GlobeNewswire

2 years ago

Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia

AVXL

Insider Monkey

2 years ago

12 $10 Stocks That Will Triple

Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference

AVXL

GlobeNewswire

2 years ago

Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference

AVXL

Insider Monkey

2 years ago

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

AVXL

Associated Press Finance

2 years ago

Latest Anavex Life Sciences Corp. (AVXL) News on October 22, 2025

Share on Social Networks: